Nanomedicine at the crossroads – Why good chemistry is not enough

18 November 2020 14:00-15:00, Germany

Introduction

Beilstein Talk

Nowadays, an emerging number of advanced therapies conquer the global market. Nanotechnology-related drug products show groundbreaking opportunities in cancer therapy. Still the translation of nanomedicines from bench to bedside poses a major challenge to the scientific community. The talk provides a snapshot of his research activities in the characterization of nanomedicines in vitro and in silico. Major hurdles in the development of novel drug delivery systems and their translation into the hospital will be discussed from the perspective of a pharmaceutical scientist